Kitov Pharmaceuticals Hldgs L Sponsored ADR (KTOV)

[EM]

Kitov Appoints Gil Efron as Deputy Chief Executive Officer and Chief Financial Officer
http://www.globenewswire.com/news-release/2018/10/11/1619923/0/en/Kitov-Appoints-Gil-Efron-as-Deputy-Chief-Executive-Officer-and-Chief-Financial-Officer.html


Maybe what Kitov needed?

He was deputy CEO and CFO of Kamada.

here from Kamada PR of September '17
http://www.kamada.com/news_item.php?ID=298
Kamada Ltd. (NASDAQ & TASE: KMDA) today announced that Gil Efron, Deputy Chief Executive Officer (Deputy CEO) & Chief Financial Officer (CFO) recently informed the Company of his plan to leave at the end of the year.

“Gil has played a key role in helping build Kamada into a leading international biopharmaceutical company,” said Amir London, Kamada’s CEO. “In his senior management position, he has been instrumental in multiple facets within the organization, including the development of the Company’s strategy, managing key processes and supporting critical corporate initiatives, such as expanding our agreements with Baxalta (now Shire), and guiding Kamada through its listing on the NASDAQ stock exchange in 2013 and our recent follow on public offering. We wish Gil all the best in his future endeavors.”

“After six years with Kamada, during which I took a leading role in the Company’s management, I believe it is time for me to move on and seek new senior management opportunities,” said Mr. Efron. “I am proud of what we have accomplished during my tenure at Kamada, including growing revenues from $34 million in 2010 to an expected $100 million and reaching profitability in 2017, as well as significantly improving the Company’s financial position.